SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-006104
Filing Date
2018-05-14
Accepted
2018-05-14 16:05:00
Documents
83
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0318_immucellcorp.htm 10-Q 635815
2 CERTIFICATION f10q0318ex31_immucellcorp.htm EX-31 9765
3 CERTIFICATION f10q0318ex32_immucellcorp.htm EX-32 6471
  Complete submission text file 0001213900-18-006104.txt   4903319

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20180331.xml EX-101.INS 981070
5 XBRL SCHEMA FILE iccc-20180331.xsd EX-101.SCH 49246
6 XBRL CALCULATION FILE iccc-20180331_cal.xml EX-101.CAL 51417
7 XBRL DEFINITION FILE iccc-20180331_def.xml EX-101.DEF 148427
8 XBRL LABEL FILE iccc-20180331_lab.xml EX-101.LAB 480711
9 XBRL PRESENTATION FILE iccc-20180331_pre.xml EX-101.PRE 322008
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 18830561
SIC: 2835 In Vitro & In Vivo Diagnostic Substances